Cargando…

Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02(A)

BACKGROUND: A malaria vaccine based on Plasmodium falciparum apical membrane antigen 1 (AMA1) elicited strain specific efficacy in Malian children that waned in the second season after vaccination despite sustained AMA1 antibody titers. With the goal of identifying a humoral correlate of vaccine-ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berry, Andrea A., Gottlieb, Eric R., Kouriba, Bourema, Diarra, Issa, Thera, Mahamadou A., Dutta, Sheetij, Coulibaly, Drissa, Ouattara, Amed, Niangaly, Amadou, Kone, Abdoulaye K., Traore, Karim, Tolo, Youssouf, Mishcherkin, Vladimir, Soisson, Lorraine, Diggs, Carter L., Blackwelder, William C., Laurens, Matthew B., Sztein, Marcelo B., Doumbo, Ogobara K., Plowe, Christopher V., Lyke, Kirsten E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339315/ https://www.ncbi.nlm.nih.gov/pubmed/30658710 http://dx.doi.org/10.1186/s12936-019-2637-x

Ejemplares similares

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine
por: Laurens, Matthew B., et al.
Publicado: (2017)

Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles
por: Tebben, Kieran, et al.
Publicado: (2023)

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children
por: Arama, Charles, et al.
Publicado: (2018)

Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial
por: Laurens, Matthew B., et al.
Publicado: (2013)

Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children
por: Travassos, Mark A., et al.
Publicado: (2015)

Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuation
por: Ventimiglia, Noah T., et al.
Publicado: (2021)

Differential Recognition of Terminal Extracellular Plasmodium falciparum VAR2CSA Domains by Sera from Multigravid, Malaria-Exposed Malian Women
por: Travassos, Mark A., et al.
Publicado: (2015)

Gene expression analyses reveal differences in children’s response to malaria according to their age
por: Tebben, Kieran, et al.
Publicado: (2023)

Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2010)

Host and Parasite Transcriptomic Changes upon Successive Plasmodium falciparum Infections in Early Childhood
por: Bradwell, Katie R., et al.
Publicado: (2020)

Safety and Allele-Specific Immunogenicity of a Malaria Vaccine in Malian Adults: Results of a Phase I Randomized Trial
por: Thera, Mahamadou A, et al.
Publicado: (2006)

Long-term Maintenance of CD4 T Cell Memory Responses to Malaria Antigens in Malian Children Coinfected with Schistosoma haematobium
por: Lyke, Kirsten E., et al.
Publicado: (2018)

Gene expression analyses reveal differences in children’s response to malaria according to their age
por: Tebben, Kieran, et al.
Publicado: (2023)

Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali
por: Coulibaly, Drissa, et al.
Publicado: (2014)

First characterization of methanogens in oral cavity in Malian patients with oral cavity pathologies
por: Sogodogo, Elisabeth, et al.
Publicado: (2019)

Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali
por: Coulibaly, Drissa, et al.
Publicado: (2013)

Spatio-Temporal Dynamics of Asymptomatic Malaria: Bridging the Gap Between Annual Malaria Resurgences in a Sahelian Environment
por: Coulibaly, Drissa, et al.
Publicado: (2017)

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008)

Reduced T Regulatory Cell Response during Acute Plasmodium falciparum Infection in Malian Children Co-Infected with Schistosoma haematobium
por: Lyke, Kirsten E., et al.
Publicado: (2012)

Antigen-Specific B Memory Cell Responses to Plasmodium falciparum Malaria Antigens and Schistosoma haematobium Antigens in Co-Infected Malian Children
por: Lyke, Kirsten E., et al.
Publicado: (2012)

Candidate Polymorphisms and Severe Malaria in a Malian Population
por: Toure, Ousmane, et al.
Publicado: (2012)

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
por: Thera, Mahamadou A., et al.
Publicado: (2016)

Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination
por: Bailey, Jason A., et al.
Publicado: (2020)

Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2014)

Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2016)

Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali
por: Ouattara, Amed, et al.
Publicado: (2011)

Protection of Malian children from clinical malaria is associated with recognition of multiple antigens
por: Daou, Modibo, et al.
Publicado: (2015)

Successful Profiling of Plasmodium falciparum var Gene Expression in Clinical Samples via a Custom Capture Array
por: Stucke, Emily M., et al.
Publicado: (2021)

New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali
por: Dara, Antoine, et al.
Publicado: (2017)

Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets
por: Travassos, Mark A., et al.
Publicado: (2018)

Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag
por: Stucke, Emily M., et al.
Publicado: (2019)

Association of HLA alleles with Plasmodium falciparum severity in Malian children
por: Lyke, K E, et al.
Publicado: (2011)

Dynamics of Polymorphism in a Malaria Vaccine Antigen at a Vaccine-Testing Site in Mali
por: Takala, Shannon L, et al.
Publicado: (2007)

Blastocystis Colonization Is Associated with Increased Diversity and Altered Gut Bacterial Communities in Healthy Malian Children
por: Kodio, Aly, et al.
Publicado: (2019)

Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate Plasmodium falciparum Reticulocyte–Binding Protein Homologue-5 in Kalifabougou, Mali
por: Ouattara, Amed, et al.
Publicado: (2018)

Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure
por: Zhou, Albert E., et al.
Publicado: (2019)

Natural immunity to malaria preferentially targets the endothelial protein C receptor-binding regions of PfEMP1s
por: Tewey, Madison A., et al.
Publicado: (2023)

Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome
por: Berry, Andrea A., et al.
Publicado: (2021)

Immunogenomic profile at baseline predicts host susceptibility to clinical malaria
por: Mbambo, Gillian, et al.
Publicado: (2023)

A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa
por: Takala, Shannon L, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_sfh09k2fc9mkrsuispurnm6mar